What Will Be The Market Value of Single use Bioprocessing In Next Few Years?
                     MarketsandMarkets 
Presents
        Single use Bioprocessing Market worth $20.8 billion by 2026
https://www.marketsandmarkets.com/Market-Reports/single-use-bioprocessing-market-2316
51297.html
The report "Single use Bioprocessing Market by Product (Media Bags and containers, 
Bioreactors, Mixers, Assemblies), Application (Cell Culture, Mixing, Storage, Filtration, 
Purification), End User (Biopharma Companies, CROs, CMOs) - Global Forecast 2026", is 
expected to reach USD 20.8 billion by 2026 from USD 8.2 billion in 2021, at a CAGR of 20.5% 
during the forecast period. Single-use bioprocessing is a rapidly evolving technology used to 
develop disposable bioprocessing equipment and accessories to manufacturing 
biopharmaceutical molecules such as recombinant proteins, monoclonal antibodies, vaccines, 
and stem cells. Bioprocess utilizes living cells or their components such as enzymes, bacteria, 
and others to obtain preferred products. The central idea behind using single-use bioprocessing 
technology in the bioprocess is to decrease the cost associated with complicated steps such as 
cleaning, sterilization, and maintenance of steel-based bioreactor systems.
Browse 486 market data Tables and 46 Figures spread through 369 Pages and in-depth TOC on 
"Single use Bioprocessing Market by Product (Media Bags and containers, Bioreactors, Mixers, 
Assemblies), Application (Cell Culture, Mixing, Storage, Filtration, Purification), End User 
(Biopharma Companies, CROs, CMOs) - Global Forecast 2026"
Download a PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=231651297
Objectives of the Study:
• The single-use media bags and containers segment accounted for the largest share of the 
product segment
Based on product, the single-use bioprocessing market is categorized into single-use media 
bags and containers, single-use assemblies, single-use bioreactors, disposable mixers, and 
other products. The other products segment includes single-use vessels, tubing, 
connectors. In 2020, the single-use media bags and containers segment accounted for the 
largest share of 30.7% of the global single-use bioprocessing market by product. Single-use 
bioprocessing systems offer benefits such as lower capital investment, lower operating 
expenses, and lower environmental footprint, thus driving the growing adoption of these 
systems in biopharmaceutical applications.
• The filtration segment accounted for the largest share of the application segment
• The Asia Pacific region is the fastest-growing region
Speak to Analyst: 
https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=231651297
 
This report categorizes the single use bioprocessing market into the following segments and 
subsegments:
Single use Bioprocessing Market, by Product
• Single-use media bags and containers
• Single-use assemblies
• Single-use bioreactors
• Disposable mixers
• Other products
Single use Bioprocessing Market, by Application
• Filtration
• Storage
• Cell culture
• Mixing
• Purification
Single use Bioprocessing Market, by End user
• Biopharmaceutical & Pharmaceutical companies
• Contract Research Organizations and contract manufacturing organizations (CROs & CMOs)
• Academic & Research institutes
The single-use bioprocessing market is highly consolidated with majority of the market 
share taken up by key players such as Thermo Fisher Scientific (US), Danaher 
Corporation (US), Sartorius Stedim Biotech S.A. (France), and Merck KGaA (Germany). 
The key players in this market are increasingly focusing on strategic expansions, 
partnerships, and product approvals to expand their manufacturing capabilities and 
increase market presence.
Companies Insight
Sartorius Stedim Biotech held the leading position in the single-use bioprocessing market in 
2020. Sartorius focuses on strengthening its position in the market by adopting organic and 
inorganic strategies such as product launches and expansions. During the past three years, 
Sartorius Stedim Biotech launched SUB systems such as BIOSTAT STR Generation 3 Single-Use 
Bioreactor, BIOSTAT RM TX Single-Use Bioreactor, and BIOSTAT STR. In 2019, Sartorius acquired 
Danaher’s Life Science portfolio, which is complementary to the portfolio of Sartorius’s 
laboratory and bioprocess business. In 2019, the company also expanded their operations in 
Puerto Rico.
Thermo Fisher Scientific is the second-largest player in the single-use bioprocessing market. 
Thermo Fisher Scientific operates in the single-use bioprocessing market through the life science 
solutions business segment. To further increase its share in the single-use bioprocessing market, 
the company focuses on growth strategies such as acquisitions and expansion. From 2019 to 
2021, the company expanded its business in the US. The company also made investments worth 
~USD 650 million from 2019 to 2021 to enhance their single-use bioprocessing capabilities and 
increase their market share.
Contact Us
Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
[email protected]
Press release: 
https://www.marketsandmarkets.com/PressReleases/single-use-bioprocessing.asp
Research insights: 
https://www.marketsandmarkets.com/ResearchInsight/single-use-bioprocessing-market.asp
About MarketsandMarkets
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche 
opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently 
servicing 5000 customers worldwide including 80% of global Fortune 1000 companies as clients. 
Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for 
their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets 
following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with 
the clients to identify new opportunities, identify most important customers, write "Attack, avoid 
and defend" strategies, identify sources of incremental revenues for both the company and its 
competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top 
players across leaders, emerging companies, innovators, strategic players) annually in high growth 
emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies 
this year for their revenue planning and help them take their innovations/disruptions early to the 
market by providing them research ahead of the curve.
MarketsandMarkets’s flagship competitive intelligence and market research platform, "RT" 
connects over 200,000 markets and entire value chains for deeper understanding of the unmet 
insights along with market sizing and forecasts of niche markets.